glp-1 drug novo nordisk Nordisk's weight-loss pill wins FDA approval FDA seeks to limit mass

Polyunsaturated fatty acids and their effects on cardiovascular disease

If present, discontinuation should be considered, following the ASA guidance: withholding on the day of surgery for daily formulations and 1 week prior for weekly ones

If youre wondering whether your situation qualifies, heres what your lawyer will consider: Exposure history: Do your pharmacy records or EHR notes verify that you used a qualifying GLP-1 medication, that your dosage increased over time, and that your injury occurred within a plausible exposure window

While it is available as a dietary supplement and has shown positive results, such as in animal research, clinical studies still need to take a closer look at its efficacy and safety in various applications